Study attempts to find out how India made expensive diabetes medicines affordable
India’s low medication prices are tied to its role as a major pharmaceutical exporter, supported by legislation that prevents ‘patent evergreening’ and enables generic drug manufacturing, says a study by diabetologists
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
The HinduStudy attempts to find out how India made expensive diabetes medicines affordableThe HinduStudy attempts to find out how India made expensive diabetes medicines affordable9 recorded states
Signal first indexedP1 · 68% quality · 1 source
Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources
Quality 72→76P1 · 76% quality · 2 sources
Quality 76→80P1 · 80% quality · 2 sources
Quality 80→84P1 · 84% quality · 2 sources
Quality 84→88P1 · 88% quality · 2 sources
Quality 88→92P1 · 92% quality · 2 sources
Quality 92→96P1 · 96% quality · 2 sources
Quality 96→99P1 · 99% quality · 2 sources